1. Home
  2. AHH vs BCAX Comparison

AHH vs BCAX Comparison

Compare AHH & BCAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AHH
  • BCAX
  • Stock Information
  • Founded
  • AHH 1979
  • BCAX 2018
  • Country
  • AHH United States
  • BCAX United States
  • Employees
  • AHH N/A
  • BCAX N/A
  • Industry
  • AHH Real Estate
  • BCAX
  • Sector
  • AHH Finance
  • BCAX
  • Exchange
  • AHH Nasdaq
  • BCAX NYSE
  • Market Cap
  • AHH 599.4M
  • BCAX 670.9M
  • IPO Year
  • AHH 2013
  • BCAX 2024
  • Fundamental
  • Price
  • AHH $6.91
  • BCAX $11.77
  • Analyst Decision
  • AHH Buy
  • BCAX Strong Buy
  • Analyst Count
  • AHH 3
  • BCAX 6
  • Target Price
  • AHH $11.25
  • BCAX $34.20
  • AVG Volume (30 Days)
  • AHH 1.4M
  • BCAX 622.0K
  • Earning Date
  • AHH 05-08-2025
  • BCAX 05-16-2025
  • Dividend Yield
  • AHH 10.91%
  • BCAX N/A
  • EPS Growth
  • AHH N/A
  • BCAX N/A
  • EPS
  • AHH 0.34
  • BCAX N/A
  • Revenue
  • AHH $708,715,000.00
  • BCAX N/A
  • Revenue This Year
  • AHH N/A
  • BCAX N/A
  • Revenue Next Year
  • AHH $2.54
  • BCAX N/A
  • P/E Ratio
  • AHH $20.29
  • BCAX N/A
  • Revenue Growth
  • AHH 6.23
  • BCAX N/A
  • 52 Week Low
  • AHH $6.81
  • BCAX $11.10
  • 52 Week High
  • AHH $12.46
  • BCAX $28.09
  • Technical
  • Relative Strength Index (RSI)
  • AHH 18.57
  • BCAX N/A
  • Support Level
  • AHH $7.48
  • BCAX N/A
  • Resistance Level
  • AHH $7.63
  • BCAX N/A
  • Average True Range (ATR)
  • AHH 0.25
  • BCAX 0.00
  • MACD
  • AHH -0.02
  • BCAX 0.00
  • Stochastic Oscillator
  • AHH 8.12
  • BCAX 0.00

About AHH Armada Hoffler Properties Inc.

Armada Hoffler Properties Inc is a real estate company. It engages in developing, building, owning and managing the high-quality, institutional-grade office, retail, and multifamily properties in various markets throughout the Mid-Atlantic and Southeastern United States. It lease its properties under operating leases and recognize base rents. It also recognize revenue from tenant recoveries, through which tenants reimburses the company for expenses paid by them such as utilities, janitorial, repairs and maintenance. The company's operating segment includes office real estate, retail real estate, multifamily residential real estate, and general contracting, real estate financing and real estate services. It generates maximum revenue from the retail real estate segment.

About BCAX BICARA THERAPEUTICS INC

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

Share on Social Networks: